Clinical Trial Update: NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT) [Phase 2]

View source ↗

Summary

Phase 2 trial update for NM-IL-12 in Cutaneous T-Cell Lymphoma undergoing total skin electron beam therapy (TSEBT).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• NM-IL-12

Snippet

Sponsor: Neumedicines Inc. | Conditions: Cutaneous T Cell Lymphoma (CTCL), Mycosis Fungoides | Phase 2 | Status: UNKNOWN